Avalyn Pharma Inc.
Clinical trials sponsored by Avalyn Pharma Inc., explained in plain language.
-
Breathing new hope: Long-Term test for inhaled lung scarring treatment
Disease control Recruiting nowThis study aims to check the long-term safety and side effects of an inhaled medication for people with progressive lung scarring (pulmonary fibrosis). It is open to people who have already completed a previous study with this type of inhaled drug. Participants will use the medic…
Phase: PHASE2 • Sponsor: Avalyn Pharma Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
New inhaled treatment aims to halt deadly lung scarring
Disease control Recruiting nowThis study is testing whether an inhaled version of a medication called pirfenidone (AP01) can slow the progression of progressive pulmonary fibrosis (PPF), a serious lung scarring disease. About 375 participants will be randomly assigned to receive either a high dose, a low dose…
Phase: PHASE2 • Sponsor: Avalyn Pharma Inc. • Aim: Disease control
Last updated Mar 24, 2026 12:03 UTC